1. Home
  2. BW vs EVMN Comparison

BW vs EVMN Comparison

Compare BW & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Babcock & Wilcox Enterprises Inc.

BW

Babcock & Wilcox Enterprises Inc.

HOLD

Current Price

$8.36

Market Cap

657.7M

Sector

Industrials

ML Signal

HOLD

EVMN

Evommune Inc.

N/A

Current Price

$19.74

Market Cap

628.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BW
EVMN
Founded
1867
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
657.7M
628.9M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
BW
EVMN
Price
$8.36
$19.74
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$5.50
$38.60
AVG Volume (30 Days)
3.1M
329.7K
Earning Date
11-04-2025
02-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$721,285,000.00
$13,000,000.00
Revenue This Year
N/A
$89.43
Revenue Next Year
$4.85
N/A
P/E Ratio
N/A
N/A
Revenue Growth
80.30
160.00
52 Week Low
$0.22
$13.89
52 Week High
$8.58
$24.03

Technical Indicators

Market Signals
Indicator
BW
EVMN
Relative Strength Index (RSI) 70.44 N/A
Support Level $7.80 N/A
Resistance Level $8.58 N/A
Average True Range (ATR) 0.65 0.00
MACD 0.25 0.00
Stochastic Oscillator 93.64 0.00

Price Performance

Historical Comparison
BW
EVMN

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: